Literature DB >> 6028240

Death in asthmatics.

T E Van Metre.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 6028240      PMCID： PMC2441155     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN： 0065-7778


× No keyword cloud information.
  10 in total

1.  A HISTORICAL ACCOUNT OF DEATH FROM ASTHMA.

Authors:  H L ALEXANDER
Journal:  J Allergy       Date:  1963 Jul-Aug

2.  RESUSCITATION OF THE MORIBUND ASTHMATIC PATIENT: THE USE OF A POSITIVE-PRESSURE RESPIRATOR WITH CURARIZATION AND ENDOTRACHEAL INTUBATION.

Authors:  M J DREW; M J SANDO
Journal:  Med J Aust       Date:  1965-08-07       Impact factor: 7.738

3.  Recognition and treatment of potentially.

Authors:  R FELDMAN
Journal:  Ann Intern Med       Date:  1962-07       Impact factor: 25.391

4.  Causes of death and pathologic findings in 304 cases of bronchial asthma.

Authors:  J W MESSER; G A PETERS; W A BENNETT
Journal:  Dis Chest       Date:  1960-12

5.  An unusual death associated with tranquilizer therapy.

Authors:  P E FELDMAN
Journal:  Am J Psychiatry       Date:  1957-05       Impact factor: 18.112

6.  The use and abuse of pocket nebulizers in the treatment of asthma.

Authors:  M C HARRIS
Journal:  Postgrad Med       Date:  1958-02       Impact factor: 3.840

7.  Untoward reactions to tranquilizing drugs.

Authors:  D W WARDELL
Journal:  Am J Psychiatry       Date:  1957-02       Impact factor: 18.112

8.  Fatal bronchial asthma; a series of fifteen cases with a review of the literature.

Authors:  B V EARLE
Journal:  Thorax       Date:  1953-09       Impact factor: 9.139

9.  Sudden death from asthma.

Authors:  C H A WALTON; D W PENNER; J C WILT
Journal:  Can Med Assoc J       Date:  1951-02       Impact factor: 8.262

10.  Correlation of clinical and autopsy findings in 176 cases of asthma.

Authors:  S S BULLEN
Journal:  J Allergy       Date:  1952-05
  10 in total
  8 in total

1.  Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma.

Authors:  Sabina Signoretti; Catherine J Wu; Sachet A Shukla; Toni K Choueiri; David A Braun; Yue Hou; Ziad Bakouny; Miriam Ficial; Miriam Sant' Angelo; Juliet Forman; Petra Ross-Macdonald; Ashton C Berger; Opeyemi A Jegede; Liudmilla Elagina; John Steinharter; Maxine Sun; Megan Wind-Rotolo; Jean-Christophe Pignon; Andrew D Cherniack; Lee Lichtenstein; Donna Neuberg; Paul Catalano; Gordon J Freeman; Arlene H Sharpe; David F McDermott; Eliezer M Van Allen
Journal:  Nat Med       Date:  2020-05-29       Impact factor: 53.440

Review 2.  Overcoming TGFβ-mediated immune evasion in cancer.

Authors:  Daniele V F Tauriello; Elena Sancho; Eduard Batlle
Journal:  Nat Rev Cancer       Date:  2021-10-20       Impact factor: 60.716

3.  Resistance to -adrenoceptor stimulants (a possible explanation for the rise in ashtma deaths).

Authors:  M E Conolly; D S Davies; C T Dollery; C F George
Journal:  Br J Pharmacol       Date:  1971-10       Impact factor: 8.739

Review 4.  The tumour microenvironment in pancreatic cancer - clinical challenges and opportunities.

Authors:  Won Jin Ho; Elizabeth M Jaffee; Lei Zheng
Journal:  Nat Rev Clin Oncol       Date:  2020-05-12       Impact factor: 66.675

5.  Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response.

Authors:  Peng Jiang; Shengqing Gu; Deng Pan; Jingxin Fu; Avinash Sahu; Xihao Hu; Ziyi Li; Nicole Traugh; Xia Bu; Bo Li; Jun Liu; Gordon J Freeman; Myles A Brown; Kai W Wucherpfennig; X Shirley Liu
Journal:  Nat Med       Date:  2018-08-20       Impact factor: 53.440

Review 6.  Turning foes to friends: targeting cancer-associated fibroblasts.

Authors:  Xueman Chen; Erwei Song
Journal:  Nat Rev Drug Discov       Date:  2019-02       Impact factor: 84.694

7.  Clinical and genomic assessment of PD-L1 SP142 expression in triple-negative breast cancer.

Authors:  Sung Gwe Ahn; Seon-Kyu Kim; Jonathan H Shepherd; Yoon Jin Cha; Soong June Bae; Chungyeul Kim; Joon Jeong; Charles M Perou
Journal:  Breast Cancer Res Treat       Date:  2021-03-26       Impact factor: 4.872

8.  Transcriptomic signatures of tumors undergoing T cell attack.

Authors:  Aishwarya Gokuldass; Aimilia Schina; Martin Lauss; Katja Harbst; Christopher Aled Chamberlain; Arianna Draghi; Marie Christine Wulff Westergaard; Morten Nielsen; Krisztian Papp; Zsofia Sztupinszki; Istvan Csabai; Inge Marie Svane; Zoltan Szallasi; Göran Jönsson; Marco Donia
Journal:  Cancer Immunol Immunother       Date:  2021-07-17       Impact factor: 6.968
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.